000 01471 a2200445 4500
005 20250517185521.0
264 0 _c20180917
008 201809s 0 0 eng d
022 _a1532-3080
024 7 _a10.1016/j.breast.2017.11.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaniels, Benjamin
245 0 0 _aTrastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001-2016).
_h[electronic resource]
260 _bBreast (Edinburgh, Scotland)
_cApr 2018
300 _a7-13 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Immunological
_xtherapeutic use
650 0 4 _aAustralia
650 0 4 _aBenchmarking
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Rate
650 0 4 _aTrastuzumab
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aKiely, Belinda E
700 1 _aLord, Sarah J
700 1 _aHoussami, Nehmat
700 1 _aLu, Christine Y
700 1 _aWard, Robyn L
700 1 _aPearson, Sallie-Anne
773 0 _tBreast (Edinburgh, Scotland)
_gvol. 38
_gp. 7-13
856 4 0 _uhttps://doi.org/10.1016/j.breast.2017.11.007
_zAvailable from publisher's website
999 _c27821918
_d27821918